Flanigans Enterprises Inc
BDL NYSE Retail-Eating Places Financials FY2016βFY2025
What Flanigans Enterprises Inc does
No business description yet.
- Legal name
- FLANIGANS ENTERPRISES INC
- Fiscal year ends
- September 27, 2025
- Latest annual report
- 10-K Β· Dec 19, 2025
- Accession Β· CIK
- 0001174947-25-001463
0000012040
Revenue and margins
Flanigans Enterprises Inc had $205M of revenue in fiscal 2025, up 9.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 5.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $4.7M in fiscal 2025, 2.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Flanigans Enterprises Inc returned $1.0M to shareholders in fiscal 2025, 22% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Flanigans Enterprises Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $32.7M | $42.1M | $25.5M | $21.4M | $20.1M |
| Debt incl. finance leases | $22.4M | $25.7M | $23.4M | $22.2M | $20.9M |
| Net debt / EBITDA | β0.9x | β2.4x | β0.3x | 0.1x | 0.1x |
| Debt / equity | 0.4x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | 9.2x | 9.2x | 6.6x | 5.7x | 9.1x |
| Current ratio | 2.0x | 2.3x | 1.6x | 1.6x | 1.7x |
| Quick ratio | 1.7x | 2.0x | 1.3x | 1.2x | 1.3x |
| Total assets | $128M | $147M | $146M | $142M | $141M |
| Total liabilities | $67.4M | $74.2M | $70.9M | $66.7M | $61.5M |
| Shareholders' equity | $51.2M | $55.7M | $59.2M | $61.2M | $65.2M |
| Net debt (β = net cash) | β$10.3M | β$16.4M | β$2.1M | $0.8M | $0.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 6 / 8 | 7 / 8 | 4 / 8 | 8 / 8 | 6 / 8 | 6 / 8 | 7 / 8 | 8 / 8 |
| Accruals ratio | β10.2% | β9.0% | β9.8% | β8.8% | β8.5% | β1.9% | β3.0% | β3.1% | β2.3% | β3.9% |
| Altman Z'' | 4.06 | 3.96 | 4.13 | 4.68 | 2.57 | 3.54 | 3.60 | 3.09 | 3.17 | 3.61 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $104M | $107M | $113M | $116M | $113M | $137M | $158M | $174M | $187M | $205M |
| Operating income | $6.8M | $6.3M | $7.4M | $6.3M | $2.9M | $8.7M | $6.9M | $7.0M | $5.8M | $8.7M |
| Interest expense | $0.6M | $0.6M | $0.8M | $0.7M | $0.8M | $0.9M | $0.8M | $1.1M | $1.0M | $1.0M |
| Pretax income | $6.3M | $5.8M | $6.8M | $6.3M | $2.1M | $18.0M | $9.8M | $6.1M | $5.6M | $8.6M |
| Income tax | $1.4M | $1.4M | $1.4M | $0.9M | β$0.1M | $1.2M | $0.8M | $0.6M | $0.3M | $0.6M |
| Net income | $3.0M | $3.0M | $3.7M | $3.6M | $1.1M | $11.8M | $6.3M | $4.0M | $3.4M | $5.0M |
| Diluted EPS | $1.64 | $1.63 | $1.98 | $1.96 | $0.60 | $6.34 | $3.40 | $2.15 | $1.81 | $2.71 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $8.8M | $8.3M | $10.0M | $9.6M | $8.8M | $14.0M | $10.5M | $8.5M | $6.6M | $10.5M |
| Capital expenditure | $3.1M | $4.3M | $2.8M | $4.3M | $2.3M | $6.5M | $4.0M | $13.2M | $3.4M | $5.8M |
| Free cash flow | $5.7M | $4.0M | $7.2M | $5.3M | $6.5M | $7.5M | $6.5M | β$4.7M | $3.2M | $4.7M |
| Depreciation and amortization | $2.6M | $2.5M | $2.7M | $2.9M | $3.1M | $3.0M | $0.0M | $0.0M | $0.0M | $4.7M |
| Acquisitions | β | β | β | β | β | β | $0.1M | β | β | β |
| Dividends paid | $0.3M | $0.4M | $0.5M | $0.5M | β | β | $1.9M | $0.8M | $0.9M | $1.0M |
| Dividends and buybacks | $0.3M | $0.4M | $0.5M | $0.5M | β | β | $1.9M | $0.8M | $0.9M | $1.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $10.2M | $9.9M | $13.4M | $13.7M | $29.9M | $32.7M | $42.1M | $25.5M | $21.4M | $20.1M |
| Total debt | $10.3M | $12.6M | $14.7M | $13.2M | $26.5M | $22.4M | $25.7M | $23.4M | $22.2M | $20.9M |
| Finance lease liabilities | β | β | β | β | $4.8M | β | β | β | β | β |
| Current assets | $15.3M | $14.6M | $19.0M | $19.6M | $36.5M | $39.8M | $50.9M | $35.3M | $31.5M | $30.6M |
| Current liabilities | $11.5M | $11.0M | $13.3M | $13.1M | $25.4M | $20.2M | $22.2M | $22.4M | $19.9M | $18.1M |
| Inventory | $2.6M | $2.8M | $3.2M | $3.3M | $3.6M | $5.1M | $6.5M | $7.2M | $7.0M | $6.9M |
| Property and equipment, net | $38.1M | $42.2M | $42.4M | $47.5M | $47.0M | $56.9M | $63.3M | $80.1M | $81.7M | $82.7M |
| Intangible assets | $0.7M | $0.5M | $0.4M | $0.3M | $0.2M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M |
| Total assets | $56.4M | $60.5M | $67.3M | $68.8M | $112M | $128M | $147M | $146M | $142M | $141M |
| Total liabilities | $27.1M | $28.5M | $32.1M | $24.2M | $66.9M | $67.4M | $74.2M | $70.9M | $66.7M | $61.5M |
| Shareholders' equity | $29.3M | $32.0M | $35.2M | $38.3M | $39.4M | $51.2M | $55.7M | $59.2M | $61.2M | $65.2M |
| Margins | ||||||||||
| Operating margin | 6.6% | 5.9% | 6.6% | 5.4% | 2.6% | 6.3% | 4.4% | 4.0% | 3.1% | 4.3% |
| EBITDA margin | 9.0% | 8.2% | 8.9% | 7.9% | 5.4% | 8.5% | 4.4% | 4.0% | 3.1% | 6.5% |
| Net margin | 2.9% | 2.8% | 3.2% | 3.1% | 1.0% | 8.6% | 4.0% | 2.3% | 1.8% | 2.5% |
| FCF margin | 5.5% | 3.7% | 6.3% | 4.6% | 5.8% | 5.5% | 4.1% | β2.7% | 1.7% | 2.3% |
| Returns | ||||||||||
| Return on capital | 18.1% | 13.7% | 16.2% | 14.3% | 8.1% | 19.7% | 16.3% | 11.0% | 8.9% | 12.3% |
| Return on capital employed | 15.1% | 12.6% | 13.8% | 11.4% | 3.3% | 8.0% | 5.5% | 5.7% | 4.8% | 7.1% |
| Return on equity | 10.4% | 9.9% | 10.9% | 9.9% | 2.9% | 26.0% | 11.8% | 7.0% | 5.6% | 8.0% |
| Return on assets | 5.4% | 5.2% | 5.8% | 5.4% | 1.2% | 9.8% | 4.6% | 2.7% | 2.3% | 3.6% |
| Return on tangible equity | 10.6% | 9.6% | 10.6% | 9.6% | 2.8% | 23.1% | 11.4% | 6.8% | 5.5% | 7.7% |
| Growth | ||||||||||
| Revenue growth | β | 3.1% | 6.2% | 2.4% | β2.8% | 21.5% | 15.2% | 10.3% | 7.4% | 9.6% |
| Net income growth | β | β0.7% | 21.8% | β0.8% | β69.6% | 961.6% | β46.4% | β36.6% | β16.1% | 50.0% |
| EPS growth | β | β0.6% | 21.5% | β1.0% | β69.4% | 956.7% | β46.4% | β36.8% | β15.8% | 49.7% |
| FCF growth | β | β30.3% | 80.6% | β25.4% | 22.1% | 14.9% | β13.5% | β172.3% | β | 46.9% |
| Share count change | β | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.0x | 0.3x | 0.1x | β0.0x | 0.2x | β0.9x | β2.4x | β0.3x | 0.1x | 0.1x |
| Debt / equity | 0.3x | 0.4x | 0.4x | 0.3x | 0.7x | 0.4x | 0.5x | 0.4x | 0.4x | 0.3x |
| Interest coverage | 12.2x | 10.4x | 9.9x | 8.9x | 3.5x | 9.2x | 9.2x | 6.6x | 5.7x | 9.1x |
| Current ratio | 1.3x | 1.3x | 1.4x | 1.5x | 1.4x | 2.0x | 2.3x | 1.6x | 1.6x | 1.7x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.2x | 1.3x | 1.7x | 2.0x | 1.3x | 1.2x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.0% | 4.0% | 2.5% | 3.7% | 2.0% | 4.7% | 2.5% | 7.6% | 1.8% | 2.8% |
| Payouts / FCF | 6.0% | 9.4% | 6.5% | 9.7% | β | β | 28.7% | β | 29.2% | 21.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 7.0 | 4.0 | 8.0 | 6.0 | 6.0 | 7.0 | 8.0 |
| Altman Z'' | 4.1 | 4.0 | 4.1 | 4.7 | 2.6 | 3.5 | 3.6 | 3.1 | 3.2 | 3.6 |
| Accruals ratio | β10.2% | β9.0% | β9.8% | β8.8% | β8.5% | β1.9% | β3.0% | β3.1% | β2.3% | β3.9% |
Source: SEC EDGAR XBRL filings (CIK 0000012040). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.